Pancreatic cancer vaccine prevents HALF of patients' tumors returning
The German firm BioNTech has led research into the development of a new breakthrough vaccine for pancreatic cancer. It prevented the disease from returning in half of patients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Germany Health | Health | Pancreas | Pancreatic Cancer | Vaccines